肾小管间质性肾炎伴葡萄膜炎综合征综述
肾小管间质性肾炎伴葡萄膜炎(TINU)是一种多系统自身免疫病,可能由药物或微生物触发,与HLA相关。主要累及眼葡萄膜和肾小管,儿童青少年高发但各年龄均可受累。多数预后良好,尚无标准治疗方案,多采用糖皮质激素或免疫调节剂,需与结节病鉴别。
要点
- TINU主要累及眼和肾小管,需与结节病鉴别。
- 多数患者预后良好,但炎症可能严重且持续。
- 无标准治疗方案,多数病例使用糖皮质激素或免疫调节剂。
核心结论
- TINU是一种多系统自身免疫病,多数患者预后良好,但尚无标准治疗方案。
研究设计与样本
- 综述,基于文献回顾和 illustrative case vignette,未报告系统检索范围。
主要发现
- TINU不常见,自40年前首次描述以来仅约200例记录在案。
- 发病率在儿童和青少年中最高,但所有年龄均可受累。
- 肾脏和眼部炎症可能严重且持续,但多数患者预后良好。
- 存在HLA抗原相关遗传易感性证据。
- TINU与结节病有许多共同特征,是主要需鉴别的疾病。
临床怎么用
- 临床需将TINU与结节病鉴别。
- 多数报告病例使用糖皮质激素或其他免疫调节剂治疗。
局限性
- 因患病率低,尚无标准治疗方案。
- 新病例可能不再被报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The syndrome of tubulointerstitial nephritis and uveitis (TINU) is a multisystemic autoimmune disorder that may occur in response to various environmental triggers, including drugs and microbial pathogens. Evidence exists of HLA antigen-related genetic predisposition to developing TINU. The resulting inflammation affects chiefly the ocular uvea and renal tubules, although other organs may be involved. TINU is uncommon; only about 200 cases are on record since its original description 40 years ago, although it is possible that new ones are no longer being reported. Although its incidence is highest in children and adolescents, all ages may be affected. Renal and ocular inflammation may be clinically severe and persistent, but the prognosis for the majority of patients with TINU is favorable. Owing to its low prevalence, no standard therapeutic protocols have been established, but most reported cases have been treated with corticosteroids or other immunomodulatory agents. TINU has many features in common with sarcoidosis, the main clinical entity from which it must be distinguished. This article begins with an illustrative case vignette, followed by an overview of the syndrome and current theories regarding its pathogenesis.
引用
- Clive DM, Vanguri VK. The Syndrome of Tubulointerstitial Nephritis With Uveitis (TINU). Am J Kidney Dis. 2018. PMID: 29429748. doi:10.1053/j.ajkd.2017.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。